Navigation Links
Sorrento Therapeutics Completes Acquisition of Concortis Biosystems
Date:12/19/2013

SAN DIEGO, Dec. 19, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) announced today that it has completed its acquisition of Concortis Biosystems, Corp., providing Sorrento with a comprehensive technology platform to create a new generation of homogenous antibody drug conjugates (ADCs) with site-specific toxin conjugation and consistent drug-antibody ratios. With the close of the deal, Sorrento has issued an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders. Based on the closing share price on December 18, 2013, the transaction is valued at $11.3 million.

With the acquisition, Sorrento adds Concortis' proprietary cytotoxic payloads as well as C-lock® and K-lock® conjugation technologies that allow for site-specific toxin conjugation to the antibody. These new technologies may improve the overall stability and potency of the ADC. First-generation conjugation technologies lead to inconsistent drug-antibody ratios, which result in a heterogeneous mixture of ADCs. This variability has been a constraining factor in unlocking the full therapeutic potential for current-generation ADCs.

The ADC technology complements Sorrento's existing development programs, particularly its G-MAB® antibody library. The G-MAB library contains a vast and diverse array of fully functional monoclonal antibodies, including antibodies that hit the historically difficult to target G-protein-coupled receptors (GPCRs). In 2015, Sorrento expects to begin clinical testing of its monoclonal antibody targeting PD-L1 as well as its ADC targeting VEGFR2.

"While our near term clinical opportunity exists in a bioequivalence trial of Cynviloq™ beginning in 2014, this ADC technology acquired from Concortis will help maximize the potential of our G-MAB library and f
'/>"/>

SOURCE Sorrento Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sorrento Enters into Definitive Agreement to Acquire Antibody Drug Conjugation Technology
2. Sorrento Therapeutics Adopts Stockholder Rights Plan
3. Sorrento Therapeutics Enters into Antibody and Vaccine Development Alliance for the Prevention and Treatment of Obesity
4. Sorrento Therapeutics Announces Closing of Public Offering of Common Stock
5. Sorrento Therapeutics Announces Pricing of Public Offering of 4,150,000 Shares of Common Stock and Listing on NASDAQ
6. Sorrento Therapeutics Secures Rights to Biomiga Diagnostics Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy
7. Sorrento Therapeutics Completes IgDraSol Merger
8. Sorrento Therapeutics to Present at Two Healthcare Conferences
9. Sorrento Therapeutics and Ben-Gurion University Sign an Agreement for the Development of Anti-Hepatitis C Virus Antibodies
10. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
11. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... NEW YORK and LONDON ... leading distributor of market intelligence, MarketResearch.com is pleased to ... IQ4I Research and Consultancy focusing on the active pharmaceutical ... IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . ... Global Market – Forecast to 2020 , ...
(Date:11/26/2014)... Nov. 25, 2014 Reinforcing its commitment to ... (NYSE: PHG AEX: PHIA) today announced ... (FDA) for its IQon Spectral CT , presenting ... kind technology adds a new dimension to Computed Tomography ... to characterize structures based on their material content within ...
(Date:11/26/2014)... -- Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a designer, manufacturer ... that its Chairman and CEO, Alan Shortall , ... Annual Healthcare Conference at the New York Palace Hotel ... The conference presentation will be broadcast ... To listen, please go to: http://ir.unilife.com/events.cfm . An ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2
... MADISON, N.J. and AUSTIN, Texas, May 24, 2011 ... Obstetrics & Gynecology demonstrated that adding OVA1 to ... would identify more ovarian cancers than a physician,s preoperative ... this month in the journal, which is the official ...
... May 24, 2011 The Board of Directors of BD (Becton, ... quarterly dividend of 41 cents per common share, payable on June ... indicated annual dividend rate is $1.64 per share. ... leading global medical technology company that develops, manufactures and sells medical ...
Cached Medicine Technology:OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment 2OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment 3OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment 4
(Date:11/27/2014)... 27, 2014 “LAB.C” was featured on NewsWatch ... latest and coolest technology products available to consumers. Mallory Sofastaii, ... product review and shared with viewers the company offers ... Android devices. , Consumers love portability and functionality. A ... Case for the iPhone5 and 5S has a portable USB ...
(Date:11/27/2014)... HealthPostures, a leading national designer ... announced that it has entered into a new ... will put HealthPostures' products into central Indiana’s premiere ... to having its products sold through Commercial Office ... with the business decision makers in the Indianapolis ...
(Date:11/27/2014)... "The uglier, the better," says Dr. Kirk Kimmerling. "Every ... as we enjoy the ugly sweater contest." Last year's ... " It was a sight to see. She glued ... the Christmas balls were faces of the staff with Dr. ... this year, it's simple to get in on the fun. ...
(Date:11/27/2014)... Ethane Web Technologies, an ISO 9001: 2008 certified Internet ... discount on PPC service. The discount will be available for ... on 1 December 2014 and remain valid until midnight of ... professional working at Ethane Web Technologies says, "This is a ... big discount would make the service quite affordable for them. ...
(Date:11/27/2014)... November 27, 2014 Serious Buyer, Andrew ... 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum concert posters. Between ... played at the University of Alabama. Jimi Hendrix started ... Hawley, “It started with Gary Weinberger who was a ... University Programs Council. The council was responsible for bringing ...
Breaking Medicine News(10 mins):Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3Health News:Ethane Web Technologies Announces 10% Christmas Discount on PPC Service 2Health News:Serious Buyer Announces His Search For Vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum Concert Posters 2
... of feline DNA could help humans, too, scientists say , ... genome of the domestic cat ( Felis catus ), an ... popular pets and provide an excellent model for human disease. ... be traced back several generations to Sweden, was the subject ...
... High-blood-pressure patients treated for enlarged heart (left ventricular ... LVH may also have a better chance of ... Cornell Medical Center, the research is published in ... Heart Association (AHA). , An estimated 20 percent ...
... Investments,Inc. (Amex: MGT ), a holding company focused ... plans to present at the Acumen,BioFin Rodman & Renshaw ... in New York City on Wednesday, November 7, at ... of MGT Capital Investments, Inc.,will provide an overview of ...
... Group, Inc. (Nasdaq: COLY ), today announced ... Executive Officer, plans to,provide a corporate update at ... Annual Healthcare Conference at 9:50am ET on November ... Interested parties may access an audio webcast of ...
... de Latinos Unidos, a,U.S. not-for-profit organization and public ... government officials of the Mexican State,of Sonora disclosed ... an,international investigative study focusing on immigrant "dumping" which,began ... practice of U.S. employers and others who,simply deport ...
... A new Mayo Clinic study shows that massage therapy decreases pain ... 2005, 58 patients undergoing surgery participated in a pilot study to ... 30 who received massage, the mean pain scores were less than ... the most painful. , Before the massage therapy, these patients rated ...
Cached Medicine News:Health News:Preventing or reducing enlarged heart may decrease risk for diabetes 2Health News:MGT Capital Investments to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Health News:Latino Advocacy Group Investigates Immigrant 'Dumping' by U.S. Employers 2Health News:Mayo researchers: complementary therapies help patients recover after heart surgery 2Health News:Mayo researchers: complementary therapies help patients recover after heart surgery 3
... The PipetBoy Pipettor is light as a feather ... aspiration speed can be continuously adjusted. The pipette ... be autoclaved. Two dosing knobs enable fine dosing ... plastic an/or glass pipettes from 0.1 to 100 ...
Precise, safe, and fatigue-free series pipetting using graduated pip...
Inquire...
Inquire...
Medicine Products: